Qi Jiang
Impact in
- Oncology top 0.5%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Orthopedics and Sports Medicine top 0.5%
- Bone and Joint Diseases
Papers in
-
- Statistical Methods in Clinical Trials 23
- Advanced Causal Inference Techniques 7
- Hematology 17
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 7
- Co-authors
- Roger DanseySteven SnapinnSusie JunPiotr MileckiRonaldo DamiãoMichael RaderNeal D. ShoreHuei Wang
- Journals
- Journal of Clinical Oncology (8 papers)Statistics in Biopharmaceutical Research (8 papers)Therapeutic Innovation & Regulatory Science (7 papers)British Journal of Haematology (3 papers)Pharmaceutical Statistics (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Qi Jiang
107 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 3.6k
- Orthopedics and Sports Medicine 1.0k
- Pulmonary and Respiratory Medicine 1.6k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Hematology 485
Countries citing papers authored by Qi Jiang
This map shows the geographic impact of Qi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Jiang more than expected).
Fields of papers citing papers by Qi Jiang
This network shows the impact of papers produced by Qi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Jiang. The network helps show where Qi Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qi Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 18 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 33 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 9 | |
| 17 | 2019 | 13 | |
| 18 | 2015 | 12 | |
| 19 | Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study Hit paper breakdown → | 2010 | 1102 |
| 20 | 2007 | 34 |
About Qi Jiang
Qi Jiang is a scholar working on Statistics and Probability, Hematology, Oncology, Critical Care and Intensive Care Medicine and Gastroenterology, having authored 111 papers that have together received 5.8k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (23 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Bone health and treatments (11 papers), Acute Myeloid Leukemia Research (10 papers), Respiratory Support and Mechanisms (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Advanced Causal Inference Techniques (7 papers) and Hematopoietic Stem Cell Transplantation (7 papers). The work is most often cited by research in Oncology (3.6k citations), Orthopedics and Sports Medicine (1.0k citations), Pulmonary and Respiratory Medicine (1.6k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Hematology (485 citations). Qi Jiang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Roger Dansey, Steven Snapinn, Susie Jun, Piotr Milecki, Ronaldo Damião, Michael Rader, Neal D. Shore, Huei Wang, Janet E. Brown and Carsten Goessl. Their work appears in journals such as Journal of Clinical Oncology, Statistics in Biopharmaceutical Research, Therapeutic Innovation & Regulatory Science, British Journal of Haematology and Pharmaceutical Statistics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.